People

Steven Gillis

Steven Gillis

Managing Director at ARCH Venture Partners

Seattle, Washington

Signal profile Steven Gillis InvestorVC Managing Director at ARCH Venture Partners archventure.com/team/steve-gi...Seattle, Washington Steven Gillis is a Takeda external director, serving since January 2019, and a managing director at ARCH Venture Partners. He founded and led Immunex and Corixa, bringing biotechnology company formation, research and development and venture-investment experience.

Current affiliation
ARCH Venture Partners · Managing Director
Investment range
$50K – $150M
Sweet spot
$25M
Investments on record
43

Investments

$130M2026-06SonoTheraSteven Gillis
$220M2025-07Dispatch BioRobert Nelsen, Steven Gillis
$92M2025-01Be BiopharmaRobert Nelsen, Steven Gillis
$82M2024-10Be BiopharmaRobert Nelsen, Steven Gillis
$190M2024-09EGenesisSteven Gillis
$70M2024-09Lifordi ImmunotherapeuticsSteven Gillis
$21M2024-06VilyaRobert Nelsen, Steven Gillis
$5M2024-02PronirasSteven Gillis
$55M2024-01Basking BiosciencesSteven Gillis
$—2023-08TFC TherapeuticsSteven Gillis

Roles

ARCH Venture Partners

Managing Director

Current
TFC Therapeutics

Board Chairman (reported August 2023)

Current
Shire

Non-Executive Director (historical)

Current